Home > Products > CD2 & EGFR
> Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Diabody)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Diabody) (CAT#: T-BSDB-046)
Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can retarget T cells to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors therapy.
Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Glioblastoma; Medulloblastoma; Non-small cell lung cancer (NSCLC); Renal cell cancer (RCC); Solid tumors
There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-EGFR Bispecific Antibody (Tandem Diabody) (T-BSDB-046). Click the button below to contact us or submit your feedback about this product.